Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Acad Emerg Med ; 27(7): 566-569, 2020 07.
Article in English | MEDLINE | ID: covidwho-682398

ABSTRACT

The novel coronavirus, or COVID-19, has rapidly become a global pandemic. A major cause of morbidity and mortality due to COVID-19 has been the worsening hypoxia that, if untreated, can progress to acute respiratory distress syndrome (ARDS) and respiratory failure. Past work has found that intubated patients with ARDS experience physiological benefits to the prone position, because it promotes better matching of pulmonary perfusion to ventilation, improved secretion clearance, and recruitment of dependent areas of the lungs. We created a systemwide multi-institutional (New York-Presbyterian Hospital enterprise) protocol for placing awake, nonintubated, emergency department patients with suspected or confirmed COVID-19 in the prone position. In this piece, we describe the background literature and the approach we have taken at our institution as we care for a high burden of COVID-19 cases with respiratory symptoms.


Subject(s)
Betacoronavirus , Consciousness , Coronavirus Infections , Pandemics , Pneumonia, Viral , Wakefulness , COVID-19 , Coronavirus Infections/complications , Emergency Service, Hospital , Humans , Hypoxia/etiology , Pneumonia, Viral/complications , Practice Guidelines as Topic , Prone Position , SARS-CoV-2
2.
Crit Pathw Cardiol ; 19(2): 49-54, 2020 06.
Article in English | MEDLINE | ID: covidwho-158057

ABSTRACT

Novel coronavirus-19 disease (COVID-19) is an escalating, highly infectious global pandemic that is quickly overwhelming healthcare systems. This has implications on standard cardiac care for ST-elevation myocardial infarctions (STEMIs). In the setting of anticipated resource scarcity in the future, we are forced to reconsider fibrinolytic therapy in our management algorithms. We encourage clinicians to maintain a high level of suspicion for STEMI mimics, such as myopericarditis which is a known, not infrequent, complication of COVID-19 disease. Herein, we present a pathway developed by a multidisciplinary panel of stakeholders at NewYork-Presbyterian/Columbia University Irving Medical Center for the management of STEMI in suspected or confirmed COVID-19 patients.


Subject(s)
Coronavirus Infections/diagnosis , Critical Pathways/standards , Infection Control/standards , Pneumonia, Viral/diagnosis , ST Elevation Myocardial Infarction/diagnosis , ST Elevation Myocardial Infarction/therapy , COVID-19 , Cost of Illness , Delivery of Health Care/standards , Humans , Pandemics , Patient Acceptance of Health Care
SELECTION OF CITATIONS
SEARCH DETAIL